Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Hormonal Cycling in Prostate Cancer
NCT00586898Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2001
- Primary completion
- Mar 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gonadorelin, Ketoconazole Cream, bicalutamide, Testosterone TEPI patch and Estrogen vaginal cream in prostate cancer (PCa), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Response at 6 months. Started Jul 2001; status: completed.
02
Drugs
gonadorelinKetoconazole CreambicalutamideTestosterone TEPI patchEstrogen vaginal cream
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00586898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586898.